Simple Summary Pancreatic neuroendocrine tumors (pNETs) are rare, indolent cancers
whose causation is only partly understood. An increasing number of studies have uncovered …

Appendiceal neuroendocrine neoplasms (ANENs) usually present as incidental findings at
the time of appendectomy for acute appendicitis. They are rare, accounting for only 0.5–1 …

This ENETS guidance paper, developed by a multidisciplinary working group, provides an
update on the previous colorectal guidance paper in a different format. Guided by key …

Background Treatment options for patients with advanced neuroendocrine tumors are
limited. The efficacy of cabozantinib in the treatment of previously treated, progressive …

Both the incidence and prevalence of well‐differentiated neuroendocrine tumours from the
small intestine (Si‐NET) are gradually increasing. Most patients have non‐functioning …

Abstract Purpose of Review The field of neuroendocrine oncology has changed much since
the time of Oberndorfer first described and coined the term carcinoid. The purpose of this …

Treatment with the mTOR inhibitor everolimus improves progression-free survival in
pancreatic neuroendocrine tumors, but it is not known if the addition of a VEGF pathway …

Neuroendocrine tumors (NETs) represent a heterogeneous group of malignancies that arise
from neuroendocrine cells dispersed throughout the organs/tissues of the body. Treatment of …

Simple Summary As we are facing an increasing incidence of pancreatic neuroendocrine
tumors (pNETs), it appears necessary to better classify this disease—and in 2017 the WHO …

Simple Summary The medical care for patients with neuroendocrine tumors arising from the
intestines, pancreas, or stomach is frequently limited by the development resistance to …